Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0S0VR
|
|||
| Former ID |
DIB008819
|
|||
| Drug Name |
PF-5230894
|
|||
| Synonyms |
SA3Ag; PF-05230894; Staphylococcus aureus vaccine, Pfizer; Staphylococcus aureus vaccine, Wyeth; WYE-400062; Staphylococcus vaccine (MSCRAMM), Pfizer; Nosocomial staphylococcus vaccine (MSCRAMM), Inhibitex/Wyeth
Click to Show/Hide
|
|||
| Indication | Bacterial infection [ICD-11: 1A00-1C4Z; ICD-10: A00-B99] | Phase 1/2 | [1] | |
| Company |
Inhibitex Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01643941) Evaluation of a Single Vaccination of One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) and a Single Dose Level of a 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) in Healthy Adults Aged 65 to <86 Years. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.